FIELD: chemistry.
SUBSTANCE: in formula is or , is , R1 is hydrogen, halogen, nitro or amino, R2 is hydrogen or lower alkyl, R3 is hydrogen, -X- is where -Y- is a bond, -O-, -NH- or -CH2-, and R4, R5 and R6 each denotes hydrogen, R7 is (C1-C8)-alkyl, (C3-C8)-cycloalkyl, -Z-R9 or , where -Z- is -O- or -S-, and each R9 independently denotes (C1-C8)-alkyl, (C3-C8)-cycloalkyl, and R8 is -D-E-R10, in which -D- is -CONHSO2-, E is (C1-C6)-alkylene and R10 denotes -O-R11 in which R11 is hydrogen. The invention also relates to use of said compounds to prepare a medicinal agent, a pharmaceutical composition and a method of preventive and/or therapeutic treatment of overactive bladder and/or acraturesis.
EFFECT: derivatives are highly effective.
7 cl, 56 ex
Title | Year | Author | Number |
---|---|---|---|
POLYHETEROCYCLIC COMPOUNDS USED AS HIGHLY EFFECTIVE INHIBITORS OF HEPATITIS C VIRUS | 2011 |
|
RU2535664C2 |
α-PHENYL- OR PYRIDYLETHANOLAMINES AND THEIR USING AS β DRENOCEPTOR AGONISTS | 2003 |
|
RU2319698C2 |
COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
ISOQUINOLINONE DERIVATIVES USEFUL IN TREATING CANCER | 2015 |
|
RU2690853C2 |
BISPHENOL DERIVATIVES AND THEIR USE AS ACTIVITY MODULATORS OF ANDROGEN RECEPTOR | 2017 |
|
RU2767257C2 |
REGULATORS OF DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND USE | 2019 |
|
RU2803499C1 |
HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
HETEROCYCLIC IMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF | 2016 |
|
RU2686314C1 |
Authors
Dates
2010-09-20—Published
2005-09-20—Filed